“…4,12,21 Indeed, a diagnosis of CAD might be problematic in the setting of CKD, since such patients frequently do not experience ischemic symptoms, elevated cardiac biomarkers, and ECG changes. 3,4,22 Although coronary angiography has been considered the gold standard for detecting CAD, contrast media-induced nephropathy or cholesterol microembolization has emerged as serious problems.…”